Jonathan Van Ness is getting candid about his weight loss journey. In a vulnerable new video posted to TikTok this week, the ...

Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding ...

With its innovative features and the upcoming launch of a direct medication purchasing service, Gala is set to become the ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

RA was well tolerated in the Phase I trial. Now MBX is planning a Phase II trial in post-bariatric hypoglycaemia patients.

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...

Detailed price information for United Airlines Holdings Inc (UAL-Q) from The Globe and Mail including charting and trades.

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs.

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

"Coverage for these weight-loss drugs has significant cost implications for employers, as a previous KFF analysis estimated ...